Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -33.77
- Piotroski Score 1.00
- Grade Buy
- Symbol (SONN)
- Company Sonnet BioTherapeutics Holdings, Inc.
- Price $2.90
- Changes Percentage (-0.68%)
- Change -$0.02
- Day Low $2.88
- Day High $3.08
- Year High $18.72
Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 for chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy. It has a license agreement with New Life Therapeutics PTE, LTD. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin 6. Sonnet BioTherapeutics Holdings, Inc. is based in Princeton, New Jersey.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 12/12/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $2.81
- Trailing P/E Ratio 0.6
- Forward P/E Ratio 0.6
- P/E Growth 0.6
- Net Income $-18,832,694
Income Statement
Quarterly
Annual
Latest News of SONN
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Boissonnault out of federal Liberal cabinet amid multiple controversies | Watch News Videos Online
Prime Minister Trudeau announces Randy Boissonnault's stepping down amid concerns over business dealings and Indigenous ancestry. Uncertainties remain about the departure, sparking calls for his resig...
By Global News | 14 hours ago -
Russia-Ukraine war live: Biden to provide antipersonnel landmines for Ukraine - reports
President Joe Biden has approved the supply of antipersonnel landmines to Ukraine to enhance its defense against Russian forces. This decision has drawn criticism but Ukraine has committed to not use ...
By The Guardian | 1 day ago -
Biden approves anti-personnel mines for Ukraine, US official says
(Reuters) -President Joe Biden has approved provision of anti-personnel land mines to Ukraine, a U.S. official told Reuters, a step that could help slow Russian advances in its east, especially when u...
By Reuters | 1 day ago
